Interesting story on a competitor, page-13

Interesting technology and a real eye opener....

If you look at Slide 9 - They have an accuracy rate of 86% if you duplicate the original material 30 times via a CT rate of 30 for the PCR test.
With our non saliva test, we were at a higher percentage, but more importantly the graph that ADO had looked to be closer to 34 times, so in essence we would be 16 times more sensitive if we only achieved 86% with a CT rate of 34. I suspect the saliva will carry less antigens so the equivalent PCR Ct repeats that we can detect accurately will be lower. I would be very surprised if it was as low as this test.

With that in mind and getting some indication on the profit margins (remembering that our CEO has mentioned on numerous occasions that our tests are generally equivalent or cheaper to produce due to the reduction in reactive agents), exciting times ahead.
Hopefully we can push this out as fast as humanly possible.
Think of all the air travellers that should be tested before jumping on a plane and all the children who can't be vaccinated. Quite a big market for some time to come and then in 2022 we have Sepsis test coming with 20% of all deaths on this earth being caused by Sepsis and every hour delay contributing to an 8% reduced survival rate. Later this year for the Flu season in Europe / US we have Flu Type A and Flu type B mulitplexing with COVID 19.
The only worry I have is manufacturing being able to keep up with demand once we have an established product.
Cheers and GLTA.